
Find a Doctor

Michael Waters, MD, PhD, is director of the Neurovascular Division and Stroke Program and a professor in the Department of Neurology at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix. He is board certified in neurology by the American Board of Psychiatry and Neurology with subspecialty board certification in vascular neurology.
Dr. Waters’ expertise includes stroke and neurovascular disease, including signs, symptoms, diagnostics, and treatments. He is a fellow of both the American Academy of Neurology and American Heart Association and a member of the American Neurological Association, American Society of Human Genetics, and the Society of Vascular and Interventional Neurology.
Dr. Waters received his masters in genetics from Penn State University in State College, Pennsylvania, and his doctorate in biochemistry and molecular biology from The University of Florida College of Medicine in Gainesville, where he also completed his MD. He completed his residency training at the University of California – Los Angeles Department of Neurology and completed his fellowship in clinical and molecular neurogenetics at Cedars Sinai Medical Center in Los Angeles.
Dr. Waters’ research studies include genetic mechanisms of stroke, neuroprotection in stroke, multiple clinical trials investigating stroke treatments, and neurogenetic mechanisms of neuroplasticity.
For more information or to request an appointment, please call (602) 406-6262.
Fax: (602) 406-6261
- Aetna
- Arizona Foundation
- Beech Street
- Blue Cross Blue Shield
- Cigna
- First Health
- Great West
- Health Choice
- Healthnet
- Humana
- Indian Health Services
- Medicare
- Mercy Care (AHCCCS)
- Phoenix Health Plan
- Scan Healthcare
- Secure Horizon
- Tricare
- United Healthcare
- Workman's Comp
- Fellowship, Cedars Sinai Medical Center, Clinical and Molecular Neurogenetics, 2004-2005
- Residency, UCLA, Department of Neurology, 2001-2004
- Internship, University of Florida College of Medicine, 2000-2001
- MD, University of Florida College of Medicine, 2000
- PhD, University of Florida College of Medicine, Biochemistry and Molecular Biology, 1999
- MS, Pennsylvania State University, Genetics, 1989
- BS, Pennsylvania State University, 1985
- American Academy of Neurology (AAN)
- AAN Section for Neurogenetics
- AAN Section for Movement Disorders
- AAN Section for Stroke
- American Society of Human Genetics
- American Neurological Association
- Society of Vascular and Interventional Neurology
- Stroke Council, American Heart Association
- Best Doctors in America, 2011-2014
- David A. Paulus Award for Clinical Excellence, University of Florida, 2013
- Founders Award for Excellence in Translational Research, American Academy of Neurology, 2006
C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke.
Date: 06/2020
Authors: Saif Ahmad, Chirayu Pandya, Adam Kindelin, Kanchan Bhatia, Rafay Chaudhary, Alok Kumar Dwivedi, Jennifer M Eschbacher, Qiang Liu, Michael F Waters, Michael F. Waters, Md Nasrul Hoda, Andrew F. Ducruet
Fingolimod Enhances The Efficacy Of Delayed Alteplase Administration In Acute Ischemic Stroke By Promoting Anterograde Reperfusion And Retrograde Collateral Flow
Date: 11/2018
Authors: De Cai Tian, Kaibin Shi, Zilong Zhu, Jia Yao, Xiaoxia Yang, Lei Su, Sheng Zhang, Meixia Zhang, Rayna J. Gonzales, Qiang Liu, De Ren Huang, Michael F. Waters, Kevin N. Sheth, Andrew F. Ducruet, Ying Fu, Min Lou, Fu Dong Shi, Fu-Dong Shi
Activation Of Jak/Stat3 Restores Nk-Cell Function And Improves Immune Defense After Brain Ischemia
Date: 05/2018
Authors: Wei Na Jin, Andrew F. Ducruet, Qiang Liu, Samuel Xiang Yu, Michael Waters, Ming Zou, Kevin N. Sheth, Rayna Gonzales, Fu Dong Shi, Fu-Dong Shi
C-Terminal Proline Deletions in KCNC3 Cause Delayed Channel Inactivation and an Adult-Onset Progressive SCA13 With Spasticity
Date: 01/2018
Authors: Swati Khare, Kira Galeano, Yalan Zhang, Jerelyn A. Nick, Harry S. Nick, S. H. Subramony, Jacinda Sampson, Leonard K. Kaczmarek, Michael F. Waters
Protective Effects of the Angiotensin II At 2 Receptor Agonist Compound 21 in Ischemic Stroke: A Nose-To-Brain Delivery Approach
Date: 01/2018
Authors: Douglas M. Bennion, Chad H. Jones, Alex N. Dang, Jacob Isenberg, Justin T. Graham, Lena Lindblad, Oliver Domenig, Michael F. Waters, Marko Poglitsch, Colin Sumners, Ulrike Muscha Steckelings
- English


Michael Waters, MD, PhD, is director of the Neurovascular Division and Stroke Program and a professor in the Department of Neurology at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center in Phoenix. He is board certified in neurology by the American Board of Psychiatry and Neurology with subspecialty board certification in vascular neurology.
Dr. Waters’ expertise includes stroke and neurovascular disease, including signs, symptoms, diagnostics, and treatments. He is a fellow of both the American Academy of Neurology and American Heart Association and a member of the American Neurological Association, American Society of Human Genetics, and the Society of Vascular and Interventional Neurology.
Dr. Waters received his masters in genetics from Penn State University in State College, Pennsylvania, and his doctorate in biochemistry and molecular biology from The University of Florida College of Medicine in Gainesville, where he also completed his MD. He completed his residency training at the University of California – Los Angeles Department of Neurology and completed his fellowship in clinical and molecular neurogenetics at Cedars Sinai Medical Center in Los Angeles.
Dr. Waters’ research studies include genetic mechanisms of stroke, neuroprotection in stroke, multiple clinical trials investigating stroke treatments, and neurogenetic mechanisms of neuroplasticity.
For more information or to request an appointment, please call (602) 406-6262.
Fax: (602) 406-6261

- Aetna
- Arizona Foundation
- Beech Street
- Blue Cross Blue Shield
- Cigna
- First Health
- Great West
- Health Choice
- Healthnet
- Humana
- Indian Health Services
- Medicare
- Mercy Care (AHCCCS)
- Phoenix Health Plan
- Scan Healthcare
- Secure Horizon
- Tricare
- United Healthcare
- Workman's Comp
- Fellowship, Cedars Sinai Medical Center, Clinical and Molecular Neurogenetics, 2004-2005
- Residency, UCLA, Department of Neurology, 2001-2004
- Internship, University of Florida College of Medicine, 2000-2001
- MD, University of Florida College of Medicine, 2000
- PhD, University of Florida College of Medicine, Biochemistry and Molecular Biology, 1999
- MS, Pennsylvania State University, Genetics, 1989
- BS, Pennsylvania State University, 1985
- American Academy of Neurology (AAN)
- AAN Section for Neurogenetics
- AAN Section for Movement Disorders
- AAN Section for Stroke
- American Society of Human Genetics
- American Neurological Association
- Society of Vascular and Interventional Neurology
- Stroke Council, American Heart Association
- Best Doctors in America, 2011-2014
- David A. Paulus Award for Clinical Excellence, University of Florida, 2013
- Founders Award for Excellence in Translational Research, American Academy of Neurology, 2006
C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke.
Date: 06/2020
Authors: Saif Ahmad, Chirayu Pandya, Adam Kindelin, Kanchan Bhatia, Rafay Chaudhary, Alok Kumar Dwivedi, Jennifer M Eschbacher, Qiang Liu, Michael F Waters, Michael F. Waters, Md Nasrul Hoda, Andrew F. Ducruet
Fingolimod Enhances The Efficacy Of Delayed Alteplase Administration In Acute Ischemic Stroke By Promoting Anterograde Reperfusion And Retrograde Collateral Flow
Date: 11/2018
Authors: De Cai Tian, Kaibin Shi, Zilong Zhu, Jia Yao, Xiaoxia Yang, Lei Su, Sheng Zhang, Meixia Zhang, Rayna J. Gonzales, Qiang Liu, De Ren Huang, Michael F. Waters, Kevin N. Sheth, Andrew F. Ducruet, Ying Fu, Min Lou, Fu Dong Shi, Fu-Dong Shi
Activation Of Jak/Stat3 Restores Nk-Cell Function And Improves Immune Defense After Brain Ischemia
Date: 05/2018
Authors: Wei Na Jin, Andrew F. Ducruet, Qiang Liu, Samuel Xiang Yu, Michael Waters, Ming Zou, Kevin N. Sheth, Rayna Gonzales, Fu Dong Shi, Fu-Dong Shi
C-Terminal Proline Deletions in KCNC3 Cause Delayed Channel Inactivation and an Adult-Onset Progressive SCA13 With Spasticity
Date: 01/2018
Authors: Swati Khare, Kira Galeano, Yalan Zhang, Jerelyn A. Nick, Harry S. Nick, S. H. Subramony, Jacinda Sampson, Leonard K. Kaczmarek, Michael F. Waters
Protective Effects of the Angiotensin II At 2 Receptor Agonist Compound 21 in Ischemic Stroke: A Nose-To-Brain Delivery Approach
Date: 01/2018
Authors: Douglas M. Bennion, Chad H. Jones, Alex N. Dang, Jacob Isenberg, Justin T. Graham, Lena Lindblad, Oliver Domenig, Michael F. Waters, Marko Poglitsch, Colin Sumners, Ulrike Muscha Steckelings
- English